Subramaniam K - Search Results

1

Post-colonoscopy colorectal cancers identified by probabilistic and deterministic linkage: results in an Australian prospective cohort.

Subramaniam K, Ang PW, Neeman T, Fadia M, Taupin D. Subramaniam K, et al. BMJ Open. 2019 Jun 21;9(6):e026138. doi: 10.1136/bmjopen-2018-026138. BMJ Open. 2019. PMID: 31230004 Free PMC article.

2

Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.

Wang H, Fewings I, Bornman L, Shadbolt B, Fadia M, Subramaniam K. Wang H, et al. Among authors: subramaniam k. J Clin Gastroenterol. 2023 May-Jun 01;57(5):494-500. doi: 10.1097/MCG.0000000000001681. Epub 2022 Feb 28. J Clin Gastroenterol. 2023. PMID: 35220375

3

Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease.

Subramaniam K, Fallon K, Ruut T, Lane D, McKay R, Shadbolt B, Ang S, Cook M, Platten J, Pavli P, Taupin D. Subramaniam K, et al. Aliment Pharmacol Ther. 2015 Mar;41(5):419-28. doi: 10.1111/apt.13058. Epub 2015 Jan 8. Aliment Pharmacol Ther. 2015. PMID: 25580985 Free article. Clinical Trial.

4

Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitis.

Kiely CJ, Subramaniam K, Platten J, Pavli P. Kiely CJ, et al. Among authors: subramaniam k. Intern Med J. 2016 May;46(5):616-9. doi: 10.1111/imj.13057. Intern Med J. 2016. PMID: 27170239

5

Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients.

Peer FC, Miller A, Pavli P, Subramaniam K. Peer FC, et al. Among authors: subramaniam k. Intern Med J. 2017 Dec;47(12):1445-1448. doi: 10.1111/imj.13637. Intern Med J. 2017. PMID: 29224199

6

The significance of ANCA positivity in patients with inflammatory bowel disease.

Lee WI, Subramaniam K, Hawkins CA, Randall KL. Lee WI, et al. Among authors: subramaniam k. Pathology. 2019 Oct;51(6):634-639. doi: 10.1016/j.pathol.2019.07.002. Epub 2019 Aug 26. Pathology. 2019. PMID: 31466865

7

Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.

Subramaniam K, Tymms K, Shadbolt B, Pavli P. Subramaniam K, et al. Intern Med J. 2015 Nov;45(11):1154-60. doi: 10.1111/imj.12891. Intern Med J. 2015. PMID: 26337851

8

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.

Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P. Subramaniam K, et al. Intern Med J. 2014 May;44(5):464-70. doi: 10.1111/imj.12397. Intern Med J. 2014. PMID: 24612209

9

Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?

Subramaniam K, Yeung D, Grimpen F, Joseph J, Fay K, Buckland M, Talaulikar D, Elijah J, Clarke AC, Pavli P, Moore J. Subramaniam K, et al. Intern Med J. 2014 Mar;44(3):287-90. doi: 10.1111/imj.12363. Intern Med J. 2014. PMID: 24621284 Review.

10

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.

Julsgaard M, Hvas CL, Gearry RB, Gibson PR, Fallingborg J, Sparrow MP, Bibby BM, Connell WR, Brown SJ, Kamm MA, Lawrance IC, Vestergaard T, Svenningsen L, Baekdal M, Kammerlander H, Walsh A, Boysen T, Bampton P, Radford-Smith G, Kjeldsen J, Andrews JM, Subramaniam K, Moore GT, Jensen NM, Connor SJ, Wildt S, Wilson B, Ellard K, Christensen LA, Bell SJ. Julsgaard M, et al. Among authors: subramaniam k. Inflamm Bowel Dis. 2020 Jan 1;26(1):93-102. doi: 10.1093/ibd/izz110. Inflamm Bowel Dis. 2020. PMID: 31141607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page